In addition, it was revealed that an elevated amount of RORC, with expression that is considered to be downregulated in bladder cancer, has probably led to the inhibition of cell proliferation and glucose metabolism, by suppressing the binding of STAT3 to the promoter of STAT3-mediated genes. The gene discussed is STAT3; the disease is urinary bladder cancer.